Oragenics (OGEN) Stock Price
Oragenics Price
Revenue at Oragenics has contracted by 3.3% per year over the past 17 years to 37,653.00 USD. Oragenics's net margin stands at -54,858.1%, down from -616.0% several years earlier. Analysts set a median price target of 1.02 USD, implying 174.8% above the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.
Oragenics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Oragenics business model & stock analysis
Frequently asked questions about Oragenics
Analysts currently set an average price target of 1.02 USD for the Oragenics stock (median: 1.02 USD), implying +174.8 % versus the latest price. The consensus is based on 6 analyst ratings.
7 analysts currently rate the Oragenics stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Oragenics share trades at 0.33 EUR (0.37 USD).
The Oragenics share (OGEN) is listed on 5 stock exchanges, including: London (0A64.L), Frankfurt (UAVP.F), München (UAVP.MU), Düsseldorf (UAVP.DU).
The revenue cannot currently be calculated for Oragenics.
The expected profit of Oragenics is -152,283.00 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Oragenics is currently -10.41. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Oragenics stock.
The P/S cannot be calculated for Oragenics currently.
The Eulerpool Quality Score for Oragenics is 2/10.
The ISIN of Oragenics is US6840236094. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Oragenics is A2JBK2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Oragenics is OGEN. The ticker symbol is used to trade Oragenics shares on the stock exchange.
Oragenics stock
Oragenics Peer Group
Oragenics Ticker
All fundamentals and in-depth analysis of Oragenics
Our stock analysis for Oragenics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oragenics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.